The store will not work correctly when cookies are disabled.
4-Morpholinyl-6-phenyl-2-thioxo-1,2-dihydropyrimidine-5-carbonitrile
ID: ALA2415044
PubChem CID: 45028809
Max Phase: Preclinical
Molecular Formula: C15H14N4OS
Molecular Weight: 298.37
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: N#Cc1c(N2CCOCC2)nc(=S)[nH]c1-c1ccccc1
Standard InChI: InChI=1S/C15H14N4OS/c16-10-12-13(11-4-2-1-3-5-11)17-15(21)18-14(12)19-6-8-20-9-7-19/h1-5H,6-9H2,(H,17,18,21)
Standard InChI Key: CCADPJPLVPHEJS-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
4.0869 -15.1503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0869 -15.9727 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8047 -16.3880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5183 -15.9727 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.5183 -15.1503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8047 -14.7348 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2320 -14.7348 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
3.3733 -16.3880 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8047 -17.2105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6597 -16.7993 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.0869 -17.6258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0869 -18.4482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8047 -18.8636 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5183 -18.4482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.5183 -17.6258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.3744 -14.7394 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3779 -13.9187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6695 -13.5080 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9551 -13.9159 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.9536 -14.7394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.6664 -15.1547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 1 0
6 1 2 0
5 7 2 0
2 8 1 0
3 9 1 0
8 10 3 0
9 11 2 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 9 1 0
1 16 1 0
16 17 1 0
16 21 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 298.37 | Molecular Weight (Monoisotopic): 298.0888 | AlogP: 2.51 | #Rotatable Bonds: 2 |
Polar Surface Area: 64.94 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.64 | CX Basic pKa: ┄ | CX LogP: 1.08 | CX LogD: 1.06 |
Aromatic Rings: 2 | Heavy Atoms: 21 | QED Weighted: 0.86 | Np Likeness Score: -1.65 |
References
1. Fargualy AM, Habib NS, Ismail KA, Hassan AM, Sarg MT.. (2013) Synthesis, biological evaluation and molecular docking studies of some pyrimidine derivatives., 66 [PMID:23811090] [10.1016/j.ejmech.2013.05.028] |